The Australian stock market entered the red zone after early trade gains and finished at 6006.4, dipped by 0.23 per cent when compared to Tuesday's closure of 6020.5.
The market reflected the negative sentiments due to further travel restrictions imposed by Queensland, and Victoria states reporting another 295 new cases.
The Australian Dollar has risen slightly by 0.34 per cent, at AEST 04:33 PM, the value remained AUD 0.7181. Gold's value dipped by 0.06 per cent, with USD 1957.51 at AEST 04:33. Crude oil was up by 0.95 per cent, and its value was USD 41.42 at AEST 04:34.
In the US stock market, benchmark indexes ended in the red zone, with NASDAQ Composite was down by 1.27 per cent, Dow Industrials dipped by 0.77 per cent, and S&P 500 fell by 0.65 per cent.
The stocks that performed well in the market today are:
- AP Eagers Limited (ASX:APE) traded at AUD 7.990 and gained 13.333 per cent.
- Mcmillan Shakespeare Limited (ASX:MMS) traded at AUD 9.290 and was up by 3.337 per cent.
The stocks that lost most points in today's market are:
- IGO Limited (ASX:IGO), which traded at AUD 4.800 and was down by 13.201 per cent.
- St Barbara Limited (ASX:SBM), which traded at AUD 3.510 and dipped by 7.632 per cent.
Now, have a look at the graph to see the top and worst-performing stocks for today's ASX trading session:
There is no one left untouched by the charm of the multibillion-dollar global boom in cannabis. Its glorious journey from a criminalized drug to being used in over 20 countries for treating medical conditions.
No wonder the cannabis stocks are on the edge of a green rush. Don’t miss out on the happenings in the cannabis sector and take advantage of the growth phase of this sector by subscribing to our report on Marijuana stocks in Australia.
Find out the drivers for the rise in cannabis stock rates Even though the cannabis sector is in its growing phase, Australian cannabis stocks have already started to rise actively due to a hastily increasing patient base, and a legislative landscape that is gradually beginning to liberalise.
Outreach and future of cannabis stocks As countries liberalise regulation for medical and recreational use of cannabis, it is predicted that the industry would grow sharply in upcoming years The global cannabis market stands currently at around $8 billion and it is expected that the hemp derived CBD market to hit approximately $22 billion by 2022.
Key Players in the sector Althea Group Holdings Limited (ASX: AGH) and Cann Group Limited (ASX: CAN) are amongst the top players. Other Australia cannabis market players are- MGC Pharmaceuticals Ltd (ASX: MXC), Elixinol Global Limited (ASX: EXL), THC Global Group Limited (ASX: THC), AusCann Group Holdings Limited (ASX: AC8)